Peter Thompson - Profile and Investment Details

Investor Profile

Peter Thompson is a Venture Capital, Private Equity Firm, Investor based in Bellevue, Washington, United States with a diverse investment portfolio that includes companies such as Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics, Olema Oncology, Aerin Medical, CoreMap, NewMed Medical, BioShin, Scribe Therapeutics, X4 Pharmaceuticals, Visen Pharmaceuticals, Abbisko Therapeutics, Sonendo, Cullinan Oncology, Silverback Therapeutics, Harbour Biomed, Nuvation Bio, Corvus Pharmaceuticals, Century TherapeuticsGentiBio, Decibel Therapeutics, Cytek Biosciences, Caris Life Sciences, UNUM Therapeutics, Scorpion Therapeutics, Crossover Health, PMV Pharmaceuticals, Immvira, Verona Pharma, Adagio Therapeutics, Zhaoke Ophthalmology Pharmaceutical, Strategicon Partners, Pandion Therapeutics, Adimab, Cleave Therapeutics, Adicet Bio, BlossomHill Therapeutics, Ikena Oncology, AbCellera Biologics, Nucleix, Aspen Neuroscience, VectivBio, GrayBug, ReViral, Harmony Biosciences, Graphite Bio, Principia Biopharma, RayzeBio, Erasca, MobileODT, Terns Pharmaceuticals, Repare Therapeutics, AnchorDx, Ventyx Biosciences, Clover Biopharmaceuticals, Protekt Therapeutics, Nuohui Health, I-Mab Biopharma, InventisBio, Prelude Therapeutics, Gracell Biotechnologies, Ruipeng Pet Healthcare, Cleave Biosciences, Janux Therapeutics, ImmPACT Bio USA, ORIC Pharmaceuticals, MBX Biosciences, Enliven Therapeutics, Acutus Medical, Foamix, Miaoshou Doctor, Delfi Diagnostics, Rongchang Pharmaceutical, Remegen, Noctrix Health, MabPlex International, Passage Bio, Chinook Therapeutics, Keros Therapeutics, Alizé Pharma, Chemomab, MDClone, Fore Biotherapeutics, VelosBio, Achilles Therapeutics, Galecto, NeuroPace, Kinnate Biopharma, Q32 Bio, Azura Ophthalmics, ReCode Therapeutics, TytoCare, ESCAPE Bio, Arcutis Biotherapeutics, . Over time, Peter Thompson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Peter Thompson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Investment Management, Life Science, Information Technology (IT), Mobile, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Clinical Trials, FinTech, Research, Health Diagnostics, Digital Health, Travel, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Peter Thompson, as their portfolio suggests a familiarity and interest in this area.

Understanding Peter Thompson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.